Stock Market News2 months Eli Lilly’s miss explanation is ‘totally opaque’, says Jim Cramer YouTube
Eli Lilly’s miss explanation is ‘totally opaque’, says Jim Cramer.
X21 hours Eli Lilly (LLY) Stock Sinks As Market Gains: What You Should Know Zacks
X2 days Eli Lilly, Novo Nordisk Stocks Rise. Only One Is Operating From a Position of Strength. Yahoo Finance
X2 days Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It Zacks
X2 days Lilly’s Zepbound Receives FDA Approval for Sleep Apnea Zacks
X2 days Eli Lilly, Novo Nordisk Stocks Rise. One of These Obesity Drugmakers Just Hit a Landmark. Yahoo Finance
X2 days Stocks to Watch Monday: Honda, Novo Nordisk, Eli Lilly, Xerox Yahoo Finance
X4 days Is Now a Good Time to Buy the Dip in Eli Lilly Stock? Yahoo Finance
X5 days Eli Lilly’s Obesity Drug Wins Approval In Sleep Apnea; Will ResMed Dive? Investor's Business Daily
X5 days Stocks to Watch Friday: Trump Media, Novo Nordisk, Eli Lilly, Tesla Yahoo Finance
X5 days Stocks on the Move: Uber, Carmax, Novo Nordisk, Eli Lilly, Merck, Crown Castle and Accenture YouTube
X5 days Nvidia, Eli Lilly lead Friday’s market cap stock movers Investing.com
X5 days There’s a New Obesity King The Wall Street Journal
X5 days Eli Lilly: Improved Competitive Position In Obesity Market, But Strong Execution Is A Must Now Seeking Alpha
X5 days LLY Stock Up as FDA Removes Mounjaro, Zepbound From Shortage List Zacks
X5 days FedEx, Eli Lilly, Occidental rise premarket; Nike, Novo Nordisk fall Investing.com
X5 days Novo Nordisk’s new weight-loss drug works better, but not as well as expected MarketWatch
X6 days Lightning Round: M&T Bank is a buy, I like the banks, says Jim Cramer YouTube
X6 days Eli Lilly dips despite FDA confirming shortage of GLP-1 tirzepatide is over Investing.com
X6 days Jim Cramer: Powell confused people yesterday YouTube
X6 days IBD 50’s Hims & Hers Tumbles After FDA Pulls Lilly’s Weight-Loss Drug From Shortage List Investor's Business Daily
X6 days FDA says Eli Lilly’s weight loss drug Zepbound is no longer in shortage CNBC
X6 days Zealand Pharma And Eli Lilly: Strategic Focus On Weight Management And Future Outlook Seeking Alpha
X7 days Lightning Round: Uber is attractive at these levels, says Jim Cramer YouTube
X7 days Jim Cramer talks the Fed’s 25 bps cut and the market’s reaction YouTube
X7 days Immigration policy could complicate Fed’s job in 2025, says Jim Cramer YouTube
X7 days Jim Cramer explains why the market melted down after the Fed cut rates CNBC
X1 week Is Jim Cramer’s ‘Cult Stocks’ Call the Beginning of the End, or the End of the Beginning? 24/7 Wall St.
X1 week Jim Cramer Signals Potential Bottom For Nvidia At $127 After Predicting ‘Vicious’ Reversal Earlier Yahoo Finance
X1 week Eli Lilly’s Alzheimer’s treatment approved in China Investing.com
X1 week Eli Lilly Alzheimer’s drug donanemab approved in China Investing.com
X1 week Lightning Round: Ford’s warranty problems will come back to haunt it, says Jim Cramer YouTube
X1 week Jim Cramer on navigating volatility YouTube
X1 week We’ve experienced this level of oversold negativity twice in 2024, says Jim Cramer YouTube
X1 week Eli Lilly (LLY) Stock Moves -0.05%: What You Should Know Zacks
X1 week NVS vs. LLY: Which Stock Should Value Investors Buy Now? Zacks
X1 week 15 Billion Reasons to Love Eli Lilly Stock Right Now Yahoo Finance
X1 week Nothing Works The Same Way Forever – Why Jim Cramer Says You Must Always Be Ready And Willing To Adjust Your Trading Strategy Yahoo Finance
X1 week Eli Lilly: A Rare Buying Opportunity Seeking Alpha
X1 week Lightning Round: I’m not touching Dow until January, says Jim Cramer YouTube
X1 week Jim Cramer on if its too late to invest in Tesla YouTube
X1 week Tesla’s move since the election is one for the ages, says Jim Cramer YouTube
X1 week Battle Over Weight-Loss Drugs: Can Eli Lilly, Novo Nordisk Defend Their Turf? Investor's Business Daily
X1 week EMA Panel Endorses Lilly’s Omvoh for Expanded Use in Crohn’s Disease Zacks
X2 weeks Lightning Round: I am on board with IBM, says Jim Cramer YouTube
X2 weeks I do believe we will have some dissent from Fed board members, says Jim Cramer YouTube
X2 weeks Eli Lilly’s Manjaro gains on Novo Nordisk’s Wegovy in UK Investing.com
X2 weeks We’re about to have a president who is the corner man for business, says Jim Cramer YouTube
X2 weeks Lightning Round: I don’t think Star Bulk’s yield can hold up, says Jim Cramer YouTube
X2 weeks Jim Cramer breaks down President-Elect Trump’s visit to the NYSE today YouTube
X2 weeks President-elect Trump to Jim Cramer: ‘Some very good days ahead’ for the American investor YouTube
XThe Stock Market News
TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.